Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia

被引：0
|
作者：
C. Crotti
F. Zucchi
C. Alfieri
R. Caporali
M. Varenna
机构：
[1] ASST-Pini-CTO,Department of Rheumatology
[2] University of Milan,Department of Clinical Sciences and Community Health
[3] Foundation Ca’ Granda IRCCS Ospedale Maggiore Policlinico,Department of Nephrology, Dialysis and Renal Transplant
来源：
Osteoporosis International | 2023年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：423 / 424
页数：1
相关论文
共 50 条
  • [31] Tumor-induced osteomalacia
    Annamalai, Anand K.
    Shinto, Ajit
    Aram, Subramanian
    Prabhu, Veeranathevar Ananji
    Santhi, Radhakrishnan
    Gopalakrishnan, Chandrasekaran
    Chelian, Mathirajan
    Srinivasan, Kaliappan Gurusamy
    KIDNEY INTERNATIONAL, 2022, 102 (05) : 1194 - 1194
  • [32] Tumor-induced osteomalacia
    Mala Kaul
    Miriam Silverberg
    Edward F. DiCarlo
    Robert Schneider
    Anne R. Bass
    Doruk Erkan
    Clinical Rheumatology, 2007, 26 : 1575 - 1579
  • [33] Two Cases of Tumor-induced Osteomalacia Resulting in Surgical Resection During Burosumab Therapy
    Nagata, Dai
    Takashi, Yuichi
    Yamamoto, Mayuko
    Toyokawa, Kyoko
    Makihata, Kensuke
    Koganemaru, Haruki
    Hideshima, Saki
    Muta, Yoshimi
    Yokomizo, Hisashi
    Fukumoto, Hironori
    Nakayama, Shizuhide
    Muta, Hiroko
    Aoki, Mikiko
    Abe, Hiroshi
    Yamamoto, Takuaki
    Hamasaki, Makoto
    Kawanami, Daiji
    INTERNAL MEDICINE, 2025,
  • [34] BUROSUMAB IMPROVES THE BIOCHEMICAL, SKELETAL, AND CLINICAL SYMPTOMS OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
    de Beur, S. Jan
    Miller, P.
    Weber, T.
    Peacock, M.
    Insogna, K.
    Kumar, R.
    Luca, D.
    Cimms, T.
    Lampl, K.
    San Martin, J.
    Carpenter, T.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S165 - S166
  • [35] BUROSUMAB IMPROVES BIOCHEMICAL, SKELETAL, AND CLINICAL FEATURES OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
    de Beur, S. Jan
    Miller, P. D.
    Weber, T. J.
    Peacock, M.
    Insogna, K. L.
    Kumar, R.
    Luca, D.
    Cimms, T.
    Roberts, M. S.
    Carpenter, T. O.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S44 - S44
  • [36] Octreotide for tumor-induced osteomalacia
    Paglia, F
    Dionisi, S
    Minisola, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1748 - 1749
  • [37] Tumor-induced osteomalacia: An overview
    Jadhav, Swati Sachin
    Shah, Ravikumar
    Patil, Virendra
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 38 (02)
  • [38] TUMOR-INDUCED OSTEOMALACIA AND RICKETS
    NUOVO, MA
    DORFMAN, HD
    SUN, CCJ
    CHALEW, SA
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (07) : 588 - 599
  • [39] A CASE OF TUMOR-INDUCED OSTEOMALACIA
    Okubo, Yuko
    Arakaki, Osao
    Yamaguchi, Sayaka
    Uezato, Hiroshi
    Takahashi, Kenzo
    JOURNAL OF DERMATOLOGY, 2014, 41 : 89 - 89
  • [40] TUMOR-INDUCED HYPOPHOSPHATEMIC OSTEOMALACIA
    AUVERTCOLIN, L
    ASSELIN, F
    HEITZMANN, A
    GOUPILLE, P
    RUCHOUX, MM
    BEUTTER, P
    VALAT, JP
    SEMAINE DES HOPITAUX, 1990, 66 (23): : 1419 - 1422
12345